Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Exp Cell Res

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    August 2022
  1. CHEN CW, Huang NK, Lee YL, Fan CK, et al
    Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib.
    Exp Cell Res. 2022;417:113219.
    PubMed     Abstract available

    May 2022
  2. LIU H, Hussain Z, Xie Q, Yan X, et al
    Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax.
    Exp Cell Res. 2022 May 11:113192. doi: 10.1016/j.yexcr.2022.113192.
    PubMed     Abstract available

    March 2022
  3. ZHANG Y, Guo H, Zhang Z, Lu W, et al
    IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
    Exp Cell Res. 2022;415:113112.
    PubMed     Abstract available

    June 2021
  4. LIU Z, Zheng W, Liu Y, Zhou B, et al
    Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells.
    Exp Cell Res. 2021 Jun 19:112708. doi: 10.1016/j.yexcr.2021.112708.
    PubMed     Abstract available

    March 2021
  5. YU W, Lutz C, Kramer A, Schmidt-Zachmann MS, et al
    The JmjC-domain protein NO66/RIOX-1 affects the balance between proliferation and maturation in acute myeloid leukemia.
    Exp Cell Res. 2021 Mar 18:112566. doi: 10.1016/j.yexcr.2021.112566.
    PubMed     Abstract available

    January 2021
  6. WANG C, Li L, Li M, Shen X, et al
    Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
    Exp Cell Res. 2021 Jan 8:112469. doi: 10.1016/j.yexcr.2020.112469.

    November 2020
  7. JAMALPOUR M, Bergquist E, Welsh M
    Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
    Exp Cell Res. 2020 Nov 18:112368. doi: 10.1016/j.yexcr.2020.112368.
    PubMed     Abstract available

  8. WANG C, Li L, Li M, Shen X, et al
    Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.
    Exp Cell Res. 2020 Nov 11:112371. doi: 10.1016/j.yexcr.2020.112371.
    PubMed     Abstract available

    October 2020
  9. ZHAO F, Sun L, Yang N, Zheng W, et al
    Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells.
    Exp Cell Res. 2020;395:112213.
    PubMed     Abstract available

    May 2020
  10. CHEN C, Wang L, Li L, Wang A, et al
    Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.
    Exp Cell Res. 2020 May 3:112054. doi: 10.1016/j.yexcr.2020.112054.
    PubMed     Abstract available

    April 2020
  11. RASHID A, Wang R, Zhang L, Yue J, et al
    Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
    Exp Cell Res. 2020 Apr 10:111989. doi: 10.1016/j.yexcr.2020.111989.
    PubMed     Abstract available

  12. LI D, Yu Z, Wang T, Li Y, et al
    The role of the novel LincRNA uc002jit.1 in NF-kB-mediated DNA damage repair in acute myeloid leukemia cells.
    Exp Cell Res. 2020 Apr 4:111985. doi: 10.1016/j.yexcr.2020.111985.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.